A value analysis model applied to the management of XXXX .

@entity1 @entity4457
PURPOSE: To assess the value of @entity4457 -related services by utilizing a health value model (HVM). Cost and quality criteria are evaluated in accordance with the interests of @entity1 , physicians, and purchasers. METHODS: We applied an HVM to a hypothetical statistical ("median") @entity1 with @entity4457 whose visual acuity is 20/80 and to a group of @entity1 with @entity4457 who are managed by our practice. We applied the model to calculate the value of these services by evaluating the responses of @entity1 and physicians and relating these responses to clinical outcomes. RESULTS: The consensus value of care for the hypothetical median @entity1 was calculated to be 0.406 (of 1.000). For those @entity1 managed in our practice, the calculated value is 0.682. Clinically, 79% achieved 20/40 or better visual acuity, and the mean final visual acuity was 0.2 logMAR (20/32). Value appraisals revealed significant concerns about the financial aspects of @entity4457 -related services, particularly among physicians. @entity1 rated services more positively than did physicians. CONCLUSIONS: Amblyopia care is difficult, sustained, and important work that requires substantial sensitivity to and support of @entity1 and families. Compliance and early detection are essential to success. The value of @entity4457 services is rated significantly higher by @entity1 than by physicians. Relative to the measured value, @entity4457 care is undercompensated. The HVM is useful to appraise clinical service delivery and its variation. The costs of failure and the benefits of success are high; high-value @entity4457 care yields substantial dividends and should be commensurately compensated in the marketplace.
